Genfit (OTCMKTS:GNFTF) Share Price Crosses Above Fifty Day Moving Average – What’s Next?

Genfit S.A. (OTCMKTS:GNFTF)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.88 and traded as high as $9.25. Genfit shares last traded at $9.25, with a volume of 250 shares.

Genfit Stock Up 15.2%

The company has a fifty day moving average price of $5.88 and a two-hundred day moving average price of $4.56.

Genfit Company Profile

Genfit is a clinical‐stage biopharmaceutical company headquartered in Lille, France, specializing in the development of innovative therapies and diagnostics for liver and metabolic diseases. The company’s research and development efforts are primarily focused on non‐alcoholic steatohepatitis (NASH), a progressive liver disorder with significant unmet medical needs. Genfit’s lead therapeutic candidate, elafibranor, is designed to target key pathways involved in inflammation, fibrosis and lipid metabolism, positioning it as a potential treatment for patients with NASH and associated metabolic complications.

In addition to its therapeutic pipeline, Genfit has established a diagnostic arm centered on NIS4®, a proprietary blood‐based test that leverages transcriptomic biomarkers to enable earlier and more accurate detection of liver fibrosis in patients at risk for NASH.